Super Immune™

Traditional Use, Formulation Logic & Research Notes

Legacy Archive · All-Season Aromatic Context

What This Archive Records

• The origin and research history of Benchmark Thyme
• Traditional aromatic context for the remaining formula materials
• Constituent-level information relevant to the formula’s functional behaviour
• The limits of the available laboratory, cell, animal, and mechanistic evidence

Traditional use and laboratory activity are not evidence that ordinary diffusion will reproduce the concentrations, exposure conditions, or outcomes used in a study.

Benchmark Thyme

Not an Ordinary Thyme Oil

Benchmark Thyme is not a single thyme chemotype, and it should not be identified simply as Thymus vulgaris.

The published University of Brighton research describes the material—then designated “Oil B”—as a proprietary blend of essential oils distilled from four UK-grown cultivars of Thymus zygis. The formulation was developed for Benchmark Oils Ltd. by Maggie Tisserand and her research collaborators.

The studied blend contained four principal components in substantial proportion:

• Thymol — 31.1%
• Linalool — 23.6%
• Alpha-terpinene — 13.2%
• Terpinen-4-ol — 11.7%

The purpose was not to produce a more pleasantly scented thyme. It was to place several antimicrobial-associated chemical families into one deliberate composition rather than relying upon a single, heavily phenolic thyme chemotype.

Why It Was Developed

Common thymol- and carvacrol-rich thyme oils can be chemically forceful but difficult to use. Benchmark Thyme was developed to retain the functional strength associated with thyme while balancing its phenolic fraction with linalool, terpinen-4-ol, and alpha-terpinene.

That distinction matters. Benchmark Thyme is not interchangeable with an ordinary bottle of thyme essential oil, nor can its research history automatically be transferred to every thyme chemotype.

The Published MRSA Research

The 2009 study tested Oil B against two methicillin-sensitive Staphylococcus aureus strains and two epidemic methicillin-resistant S. aureus strains.

Oil B demonstrated inhibitory and bactericidal activity in disc-diffusion, broth microdilution, and time-kill testing. Its reported mean minimum inhibitory concentration was 0.3%, and its mean minimum bactericidal concentration was 0.6%. At a direct-contact concentration of 5%, viable bacterial counts fell by more than three log units within two hours.

Those results were obtained through direct laboratory exposure. The study did not examine room diffusion, inhalation, cold prevention, immune support, or the finished Super Immune™ formula.

The Small Hospital Pilot

Maggie Tisserand’s later account also records a small patient-centred pilot involving three people with persistent MRSA colonisation. Diluted Benchmark Thyme was applied topically to affected sites under hospital supervision. Two patients became MRSA-negative during the trial period; the third remained positive.

This was an uncontrolled three-person pilot, not a clinical trial of diffusion and not evidence for treating systemic infection. Tisserand expressly stated that Benchmark Thyme was not a substitute for antibiotics or medical care.

The Last Remaining Material

Production of Benchmark Thyme has ended. The material held by Ananda is the last available to us from the original production.

Current batches of Super Immune™ contain that remaining material. Once it is exhausted, the formula cannot be reproduced exactly by substituting another thyme oil. The name may be similar; the composition and lineage would not be the same.

Other Formula Materials

Thyme Thymol · Thymus vulgaris ct. thymol

Traditional context: Thymol-rich thyme has a long history in strong seasonal, cleansing, and household aromatic preparations.

Functional context: This separate thyme supplies a more overtly phenolic expression than Benchmark Thyme. Research on thymol-rich thyme oils repeatedly documents direct antibacterial and antibiofilm activity in laboratory models. Those findings do not establish activity at ordinary diffuser concentrations.

Rosalina · Melaleuca ericifolia

Traditional context: Rosalina is used in Australian and contemporary aromatherapy during respiratory and seasonal periods, particularly when a less phenolic Melaleuca profile is wanted.

Functional context: Rosalina commonly contains linalool and varying amounts of 1,8-cineole. Its direct research base is considerably smaller than that of Tea Tree. Evidence from Melaleuca alternifolia may provide family-level context, but it should not be treated as proof of identical activity.

Tea Tree · Melaleuca alternifolia

Traditional context: Tea Tree has an established history in household hygiene and cleansing preparations.

Functional context: Terpinen-4-ol-rich Tea Tree oil is extensively studied for antimicrobial activity. Cell-culture research has also examined Tea Tree oil and selected constituents against influenza A virus, but those experiments involved direct cellular exposure rather than inhalation or ordinary room diffusion.

Ravintsara · Cinnamomum camphora ct. 1,8-cineole

Traditional context: Ravintsara is widely used in French-influenced aromatherapy during respiratory and higher-exposure seasons.

Functional context: Ravintsara is defined by its cineole-rich chemotype. Research on 1,8-cineole includes anti-inflammatory and antiviral models, including an influenza-infected mouse study. Animal results do not establish cold or influenza prevention through diffusion in humans.

Research boundary: The cited Cinnamomum camphora quorum-sensing study tested a linalool-dominant oil containing 22.07% eucalyptol. It provides species-level and constituent context but is not a study of Ravintsara chemotype oil.

Ravensara · Ravensara aromatica

Identity note: Ravensara and Ravintsara are different botanical materials and should not be treated as interchangeable.

Functional context: The Madagascar paper retained below is a compositional study. Its sampled leaf oils were predominantly methyl chavicol, with smaller amounts of methyl eugenol and limonene. It does not support describing true Ravensara generally as cineole- or sabinene-dominant, and it does not test antiviral or immune activity.

Lot-specific analysis is therefore important when interpreting the role of any Ravensara material.

Bay Laurel · Laurus nobilis

Traditional context: Bay Laurel has long appeared in Mediterranean household, respiratory, and cleansing traditions.

Functional context: Many leaf oils are rich in 1,8-cineole, with sabinene, linalool, and other monoterpenes contributing to the profile. Laboratory studies have examined Bay Laurel oil and 1,8-cineole against selected bacteria and fungi.

Petitgrain Bigarade · Citrus aurantium leaf and twig

Traditional context: Petitgrain is used where a highly active aromatic formula needs to remain coherent and practicable in brief inhalation or diffusion.

Functional context: Its linalool- and linalyl-acetate–leaning chemistry broadens the constituent profile and moderates the harder phenolic and camphoraceous materials. This is functional tolerability rather than decorative perfumery; Petitgrain is not presented as the formula’s principal antimicrobial driver.

Formulation Logic

Super Immune™ is a thyme-led functional aromatic rather than a fragrance blend.

The central thyme system: Benchmark Thyme provides a deliberately balanced four-cultivar composition; Thyme Thymol adds a separate, more phenolic expression.

The Melaleuca system: Tea Tree and Rosalina contribute different proportions of terpinen-4-ol, linalool, cineole, and related monoterpenes.

The cineole and laurel system: Ravintsara and Bay Laurel extend the formula through cineole-rich chemistry and additional monoterpene fractions.

The supporting system: Ravensara and Petitgrain add chemically distinct material and help keep the highly concentrated formula usable in short, intentional applications.

Some of the cited literature concerns direct antimicrobial or antiviral activity. Other papers concern constituent behaviour, biofilms, quorum sensing, or inflammatory response. These are separate forms of evidence and should not be collapsed into a general claim that the blend “boosts immunity.”

Together, they explain why the formula was constructed for periods of elevated exposure. They do not establish that inhaling Super Immune™ prevents infection or produces a measurable immune response in people.

Use Context

Super Immune™ is traditionally reached for:

• Brief diffusion during periods of elevated exposure
• Shared indoor environments, offices, visitor periods, and travel rooms
• Air travel and other enclosed public environments
• Before leaving for, or after returning from, crowded public spaces
• When the air feels heavy and a sharper, cleaner-feeling breathing environment is wanted

Current public guidance: Use in short diffusion cycles or inhale lightly from the open bottle at a comfortable distance. Stop, allow the room or senses to settle, and then decide whether more is needed.

Archive practice note: Ananda has occasionally placed one drop on the wrist area, rubbed the wrists together, and used the wrists for brief personal inhalation during air travel. Because Super Immune™ is an undiluted concentrate containing thymol-rich materials, that historical practice is not the current general-use recommendation. Current public guidance remains diffusion and brief inhalation only.

Safety Notes

• For short diffusion cycles and brief inhalation only
• Not intended for routine topical application or ingestion
• Not intended for use with children
• Avoid continuous diffusion
• Use conservatively around animals; allow pets to leave the room and avoid small enclosed spaces
• Avoid contact with the eyes and mucous membranes
• If pregnant, nursing, medically fragile, or unusually sensitive to strong aromatic materials, consult a qualified professional before use

References

The references below concern individual oils, constituents, species-level preparations, or direct laboratory models. They do not test the finished Super Immune™ formula or demonstrate that ordinary diffusion prevents illness, disinfects an occupied room, or improves immune function. The vapour- and aerosol-phase studies already presented on the product page are intentionally not repeated here.

Benchmark Oils Ltd. Benchmark Thyme.
The producer’s current material page describes Benchmark Thyme as a blend of four thyme cultivars developed to combine several antibacterial-associated aroma chemicals rather than relying upon one ordinary thyme oil. This is a manufacturer source, not an independent clinical study.
https://benchmark-thyme.com/benchmark-thyme/

Caplin JL, Allan I, Hanlon GW. Enhancing the in vitro activity of Thymus essential oils against Staphylococcus aureus by blending oils from specific cultivars. International Journal of Essential Oil Therapeutics. 2009;3(1):35–39.
This peer-reviewed laboratory study tested Oil B, a proprietary blend of oils from four UK-grown Thymus zygis cultivars, against two MSSA and two epidemic MRSA strains. It reported inhibitory and bactericidal activity under direct-contact laboratory conditions. It did not test diffusion, human illness prevention, immune function, or Super Immune™.
https://research.brighton.ac.uk/en/publications/enhancing-the-in-vitro-activity-of-thymus-essential-oils-against-/

Fani M, Kohanteb J. In vitro antimicrobial activity of Thymus vulgaris essential oil against major oral pathogens. Journal of Evidence-Based Complementary & Alternative Medicine. 2017;22(4):660–666. doi:10.1177/2156587217700772.
This study found inhibitory activity against clinical isolates of several oral bacteria and Candida albicans using agar diffusion and broth microdilution. It involved direct in vitro exposure and does not establish respiratory, immune, or diffuser effects.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5871273/

Fathy HM, Ahmed MN, Goda HA, et al. Thyme essential oil potentials as a bactericidal and biofilm-preventive agent against prevalent bacterial pathogens. Scientific Reports. 2025;15:31644. doi:10.1038/s41598-025-16485-5.
This laboratory study reported bactericidal and biofilm-inhibitory activity of a thymol-rich thyme oil against several bacterial species, including an MRSA strain. The experiments used direct exposure and molecular assays; they do not establish household diffusion or human clinical effects.
https://www.nature.com/articles/s41598-025-16485-5

Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clinical Microbiology Reviews. 2006;19(1):50–62. doi:10.1128/CMR.19.1.50-62.2006.
This review summarizes antimicrobial, anti-inflammatory, mechanistic, and limited clinical literature concerning Tea Tree oil. Much of the evidence is laboratory-based, preparation-specific, or topical and cannot be transferred directly to diffusion of the finished blend.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1360273/

Garozzo A, Timpanaro R, Stivala A, Bisignano G, Castro A. Activity of Melaleuca alternifolia (tea tree) oil on influenza virus A/PR/8: study on the mechanism of action. Antiviral Research. 2011;89(1):83–88. doi:10.1016/j.antiviral.2010.11.010.
This cell-culture study found that Tea Tree oil interfered with an early stage of influenza A viral replication when applied directly to infected cells. It did not examine inhalation, household diffusion, prevention in humans, or the finished Super Immune™ formula.
https://pubmed.ncbi.nlm.nih.gov/21095205/

Wang W, Li D, Huang X, et al. Study on antibacterial and quorum-sensing inhibition activities of Cinnamomum camphora leaf essential oil. Molecules. 2019;24(20):3792. doi:10.3390/molecules24203792.
This study reported antibacterial, antibiofilm, and quorum-sensing effects from a linalool-dominant Cinnamomum camphora leaf oil containing 22.07% eucalyptol. Because the tested oil was not the standard 1,8-cineole Ravintsara chemotype, it provides species-level context rather than direct evidence for the Ravintsara used in this formula.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6832878/

Li Y, Lai Y, Wang Y, Liu N, Zhang F, Xu P. 1,8-Cineol protects against influenza-virus-induced pneumonia in mice. Inflammation. 2016;39(4):1582–1593. doi:10.1007/s10753-016-0394-3.
This animal study found that administered 1,8-cineole reduced inflammatory changes in influenza-infected mice. It did not test an essential-oil blend, inhalation from a diffuser, or prevention or treatment in humans.
https://pubmed.ncbi.nlm.nih.gov/27351430/

Ramanoelina PAR, Rasoarahona JRE, Gaydou EM. Chemical composition of Ravensara aromatica Sonn. leaf essential oils from Madagascar. Journal of Essential Oil Research. 2006;18(2):215–217. doi:10.1080/10412905.2006.9699069.
This compositional study found that the sampled Ravensara aromatica leaf oils were predominantly methyl chavicol, with methyl eugenol and limonene also reported. It is an identity and chemistry reference, not evidence of antimicrobial, antiviral, respiratory, or immune effects.
https://www.tandfonline.com/doi/abs/10.1080/10412905.2006.9699069

Caputo L, Nazzaro F, Souza LF, Aliberti L, De Martino L, Fratianni F, Coppola R, De Feo V. Laurus nobilis: composition of essential oil and its biological activities. Molecules. 2017;22(6):930. doi:10.3390/molecules22060930.
This study characterized a Bay Laurel leaf oil rich in 1,8-cineole, sabinene, and linalool and evaluated antibacterial and antifungal activity in vitro. Its results are specific to the tested oil and direct laboratory exposure.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6152719/

Astani A, Reichling J, Schnitzler P. Screening for antiviral activities of isolated compounds from essential oils. Evidence-Based Complementary and Alternative Medicine. 2011;2011:253643. doi:10.1093/ecam/nep187.
This in vitro study tested selected phenylpropanoids and sesquiterpenes against herpes simplex virus type 1. It supplies limited constituent-level context only; it did not test Super Immune™, respiratory viruses, inhalation, or household diffusion.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3096453/